Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding: 2019-2022

Historic Shares Outstanding for Avidity Biosciences (RNA) over the last 4 years, with Sep 2022 value amounting to $54.4 million.

  • Avidity Biosciences' Shares Outstanding rose 16.10% to $54.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $54.4 million, marking a year-over-year increase of 16.10%. This contributed to the annual value of $47.8 million for FY2021, which is 27.11% up from last year.
  • As of Q3 2022, Avidity Biosciences' Shares Outstanding stood at $54.4 million, which was up 4.54% from $52.1 million recorded in Q2 2022.
  • Avidity Biosciences' Shares Outstanding's 5-year high stood at $54.4 million during Q3 2022, with a 5-year trough of $2.9 million in Q2 2019.
  • Over the past 3 years, Avidity Biosciences' median Shares Outstanding value was $37.7 million (recorded in 2021), while the average stood at $40.1 million.
  • Data for Avidity Biosciences' Shares Outstanding shows a peak YoY soared of 1,182.10% (in 2020) over the last 5 years.
  • Over the past 4 years, Avidity Biosciences' Shares Outstanding (Quarterly) stood at $3.0 million in 2019, then spiked by 1,156.91% to $37.6 million in 2020, then rose by 27.11% to $47.8 million in 2021, then grew by 16.10% to $54.4 million in 2022.
  • Its Shares Outstanding stands at $54.4 million for Q3 2022, versus $52.1 million for Q2 2022 and $49.3 million for Q1 2022.